Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Graft-Versus-Host Disease

Clinical impact of hyperacute graft-versus-host disease on results of allogeneic stem cell transplantation

Summary:

The current study defines the incidence and clinical manifestations of hyperacute graft-versus-host disease (haGVHD; fever, skin rash, diarrhea, and hepatic dysfunction) and analyzes the risk factor and the impact of haGVHD on the results of allogeneic stem cell transplantation (SCT). In all, 90 patients underwent allogeneic SCT from 71 matched siblings or 19 alternative donors. Immediate high-dose steroids were administered to 22 patients who met the criteria. The overall incidence of haGVHD was 36.7% (n=34) and haGVHD was also strongly correlated with acute (aGVHD) (P<0.001) and extensive chronic GVHD (cGVHD) (P=0.007), and found to be associated with decreased probability of relapse (P=0.0017). Early intervention with steroids within 7 days after the diagnosis of haGVHD might be associated with better survival. A survival analysis of the overall survival and disease-free survival did not reveal any difference between haGVHD+ and haGVHD− groups. In multivariate analysis, the use of an alternative donor (P=0.020) was identified as the only risk factor. Immediate high-dose steroids were effective in treating haGVHD. We conclude that in an allogeneic setting, haGVHD is not an uncommon manifestation, associated with the development of aGVHD or cGVHD. The only risk factor for haGVHD was the use of an alternative donor.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Sullivan KM, Deeg HJ, Sanders J et al. Hyperacute graft-versus-host disease in patients not given immunosuppression after allogeneic marrow transplantation. Blood 1986; 67: 1172–1175.

    CAS  Google Scholar 

  2. Spitzer TR . Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 893–898.

    Article  CAS  Google Scholar 

  3. Lee CK, Gingrich RD, Hohl RJ et al. Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation. Bone Marrow Transplant 1995; 16: 175–182.

    CAS  Google Scholar 

  4. Cahill RA, Spitzer TR, Mazumder A . Marrow engraftment and clinical manifestations of capillary leak syndrome. Bone Marrow Transplant 1996; 18: 177–184.

    CAS  Google Scholar 

  5. Colvin GA, Lambert J-F, Lum LG et al. The Haplo-Immunostorm Syndrome: a new clinical entity observed in minimal immunotherapy with outpatient haploidentical bone marrow transplantation. Blood 2002; 100: 411a.

    Google Scholar 

  6. Choi SJ, Lee KH, Lee JH et al. Peri-engraftment clinical abnormalities following allogeneic hematopoietic cell transplantation: a retrospective review of 216 patients. Bone Marrow Transplant 2003; 32: 809–813.

    Article  Google Scholar 

  7. Huang X, Chen Y, Guo N et al. Hyperacute graft versus host disease after allo-stem cell transplantation, analysis of 118 cases. Zhonghua Yi Xue Za Zhi 2002; 82: 511–514.

    PubMed  Google Scholar 

  8. Tanaka Y, Kami M, Ogawa S et al. Hyperacute graft-versus-host disease and NKT cells. Am J Hematol 2000; 63: 60–61.

    Article  CAS  Google Scholar 

  9. Maiolino A, Biasoli I, Lima J et al. Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria. Bone Marrow Transplant 2003; 31: 393–397.

    Article  CAS  Google Scholar 

  10. Horn TD . Acute cutaneous eruptions after marrow ablation: roses by other names? J Cutan Pathol 1994; 21: 385–392.

    Article  CAS  Google Scholar 

  11. Takatsuka H, Takemoto Y, Yamada S et al. Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome. Bone Marrow Transplant 2000; 26: 419–426.

    Article  CAS  Google Scholar 

  12. Nurnberger W, Willers R, Burdach S et al. Risk factors for capillary leakage syndrome after bone marrow transplantation. Ann Hematol 1997; 74: 221–224.

    Article  CAS  Google Scholar 

  13. Elmaagacli AH, Basoglu S, Peceny R et al. Improved disease-free-survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia. Blood 2002; 99: 1130–1135.

    CAS  PubMed  Google Scholar 

  14. Pan L, Teshima T, Hill GR et al. Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease. Blood 1999; 93: 4071–4078.

    CAS  Google Scholar 

  15. Reddy V, Hill GR, Pan L et al. G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient. Transplantation 2000; 69: 691–693.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr Thomas R Spitzer (Department of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, USA) for his careful review and critical advice for this paper. The great work of our nursing staff is also gratefully acknowledged.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S K Sohn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, D., Sohn, S., Kim, J. et al. Clinical impact of hyperacute graft-versus-host disease on results of allogeneic stem cell transplantation. Bone Marrow Transplant 33, 1025–1030 (2004). https://doi.org/10.1038/sj.bmt.1704479

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704479

Keywords

This article is cited by

Search

Quick links